Displaying items by tag: alabama vaccine research clinic

Many Americans say they want to “make sure the shot is safe” before getting vaccinated. That data is already in, and it is overwhelming. 

A groundbreaking clinical research trial at UAB’s Alabama Vaccine Research Clinic to compare injectable PrEP versus a daily oral regimen for HIV prevention is now recruiting participants. 

Antibody VRC01 proves safe for individuals infected with HIV-1 but only modestly controls the virus in participants who stop receiving antiretroviral therapy.
Researchers from UAB, Emory and Microsoft demonstrate that HIV has evolved to be pre-adapted to the immune response, worsening clinical outcomes in newly infected patients.
An international clinical trial for a new HIV antibody, VRC01 begins in late spring at UAB as part of the Antibody Mediated Prevention study.
UAB is recruiting postpartum women who are still lactating, for a study on the effects of the antiretroviral drug used to prevent HIV transmission.